What is the difference between dependence and withdrawal reactions? A comparison of benzodiazepines and selective serotonin re-uptake inhibitors

Addiction

Volumn 107, Issue 5, 2012, Pages 900-908

  Nielsen, Margrethe ^a   Hansen, Ebba Holme ^b   Gøtzsche, Peter C ^a  

^a Nordic Cochrane Centre   (Denmark)

^b UNIVERSITY OF COPENHAGEN   (Denmark)

Author keywords

Benzodiazepine; Dependence; DSM; ICD; SSRI; Withdrawal reactions

Indexed keywords

BENZODIAZEPINE DERIVATIVE; SEROTONIN UPTAKE INHIBITOR;

ADDICTION; COMPARATIVE STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DIFFERENTIAL DIAGNOSIS; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; REVIEW; WITHDRAWAL SYNDROME; WORLD HEALTH ORGANIZATION;

BENZODIAZEPINES; DIAGNOSIS, DIFFERENTIAL; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; HUMANS; INTERNATIONAL CLASSIFICATION OF DISEASES; SEROTONIN UPTAKE INHIBITORS; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; WORLD HEALTH ORGANIZATION;

EID: 84859309597     PISSN: 09652140     EISSN: 13600443     Source Type: Journal    
DOI: 10.1111/j.1360-0443.2011.03686.x     Document Type: Review

References (55)

1. Hollister L. E., Motzenbecker F. P., Degan R. O. Withdrawal reactions from chlordiazepoxide ('Librium'). Psychopharmacologia 1961; 2: 63-8.
2. Committee on the Review of Medicines. Systematic review of benzodiazepines. BMJ 1980; 280: 910-2.
3. Committee on Safety of Medicines. Benzodiazepines, dependence and withdrawal symptoms. Curr Probl Pharmacovigilance 1988; 21: 1-2.
4. Medawar C., Hardon A. Medicines out of Control. The Netherlands: Aksant; 2004.
5. Kramer J. C., Klein D. F., Fink M. Withdrawal symptoms following discontinuation of imipramine therapy. Am J Psychiatry 1961; 118: 548-50.
6. Haddad P. M. Antidepressant discontinuation syndromes. Clinical relevance, prevention and management. Drug Saf 2001; 24: 183-97.
7. Stoukides J. A. Extrapyramidale symptoms upon discontinuation of fluoxetine. Am J Psychiatry 1991; 148: 1263.
8. Barr L. C. Physical symptoms associated with paroxetine discontinuation. Am J Psychiatry 1994; 151: 289.
9. Einbinder E. Fluoxetine withdrawal? Am J Psychiatry 1995; 152: 1235.
10. Frost L. Shock-like sensations after discontinuation of selective serotonin reuptake inhibitors. Am J Psychiatry 1995; 512: 810.
11. Leiter F. L., Nierenberg A. A., Sanders K., Stern T. A. Discontinuation reactions following sertraline. Biol Psychiatry 1995; 38: 694-5.
12. Price J. S., Waller P. C., Wood S. M., Mackay A. V. P. A comparison of the post-marketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal. Br J Clin Pharmacol 1996; 42: 757-63.
13. Knapp M., McDavid D., Mossialos E., Thornicroft G. Mental Health Policy and Practice across Europe. Maidenhaead, Berk: Open University Press; 2007.
14. Shelton R. C. The nature of the discontinuation syndrome associated with antidepressant drugs. J Clin Psychiatry 2006; 67: 3-7.
15. Haddad P. M. Do antidepressants cause dependence? Epidemiol Psichiatr Soc 2005; 14: 58-62.
16. American Psychiatric Association. Diagnostic Statistical Manual of Mental Disorders, 3rd edn. Washington, DC: American Psychiatric Association; 1980.
17. American Psychiatric Association. Diagnostic Statistical Manual of Mental Disorders, 3rd edn revised. Washington, DC: American Psychiatric Association; 1987.
18. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th edn. Washington, DC: American Psychiatric Association; 1994.
19. ® at).
20. ® at).
21. American Psychiatric Association. The DSM-IV Sourcebook, vol. 1. Washington, DC: American Psychiatric Association; 1994.
22. Haddad P. The SSRI discontinuation syndrome. J Psychopharmacol 1998; 12: 305-13.
23. ® at).
24. Tyrer P. Benzodiazepine dependence: a shadowy diagnosis. Biochem Soc Symp 1993; 59: 107-19.
25. O'Brian C. Benzodiazepine use, abuse and dependence. J Clin Psychiatry 2005; 66: 28-33.
26. Lucki I., Rickels K., Geller A. M. Chronic use of benzodiazepines and psychomotor and cognitive test performance. Psychopharmacology 1986; 88: 426-33.
27. Marks J. The benzodiazepines: for good or evil. Neuropsychobiology 1983; 10: 115-26.
28. Fava G. A. Long-term treatment with antidepressant drugs: the spectacular achievements of propaganda. Psychother Psychosom 2002; 71: 127-32.
29. Lee S. I., Keltner N. L. Antidepressant apathy syndrome. Perspect Psychiatr Care 2005; 41: 188-92.
30. Fava G. A. Can Long-term treatment with antidepressant drugs worsen the course of depression. J Clin Psychiatry 2003; 64: 123-33.
31. Fava G. A. Potential sentisitising effects of antidepressant drugs on depression. CNS Drugs 1999; 12: 247-56.
32. Caplan P. J. They Say You're Crazy. Da Capo Press; 1995.
33. Kutchins H., Kirk S. A. Making Us Crazy. New York: Free Press; 1997.
34. Shyness L. C. How Normal Behaviour Became A Sickness. New Haven and London: Yale University Press; 2007.
35. Voyer P., McCubbin M., Cohen D., Lauzon S., Collin J., Boivin C. Unconventional indicators of drug dependence among elderly long-term users of benzodiazepines. Issues Ment Health Nurs 2004; 25: 603-28.
36. Voyer P., Préville M., Roussel M., Berbiche D., Béland S. Factors associated with benzodiazepine dependence among community-dwelling seniors. J Commun Health Nurs 2009; 26: 101-13.
37. Etter J.-F. The importance of reaching a consensual definition of dependence and of communicating this knowledge to the public. Addiction 2008; 103: 1224-5.
38. Cosgrove L., Krimsky S., Vijayaraghavan M., Schneider L. Financial ties between DSM-IV panel menbers and the pharmaceutical industry. Psychother Psychosom 2006; 75: 154-60.
39. Young A., Haddad P. Discontinuation symptom and psychotropic drugs [correspondence]. Lancet 2000; 355: 1184.
40. Schatzberg A. F., Haddad P., Kaplan E. M. Serotonin re-uptake inhibitor discontinuation syndrome: a hypothetical definition. Discontinuation panel. J Clin Psychiatry 1997; 58: 5-10.
41. Supplement J Clin Psychiatry 1997; 58.
42. ® at).
43. ® at).
44. ® at).
45. ® at).
46. Abraham J., Davis C. Drug evaluation and the permissive principle: continuities and contradictions between standards and practices in antidepressant regulation. Soc Stud Sci 2009; 39: 569-98.
47. National Institute for Clinical Excellence. CG90. Depression: The Treatment and Management of Depression in Adults. London: National Institute for Clinical Excellence; 2007.
48. Selective serotonin re-uptake inhibitors and withdrawal reactions. WHO Drug Inf 1998; 12: 136-8.
49. Coupland N. J., Bell C. J., Potokar J. P. Serotonin reuptake inhibitor withdrawal. J Clin Pharmacol 1996; 16: 356-62.
50. WHO Technical Report series no 915. WHO Expert Committee on Drug Dependence. Thirty-third Report. Geneva: WHO; 2003.
51. ® at).
52. ® at).
53. Leydon G. M., Rodgers L., Kendrick T. A qualitative study of patient views on discontinuing long-term selective serotonin reuptake inhibitors. Fam Pract 2007; 24: 570-5.
54. Rosenbaum J. F., Fava M., Hoog S. L., Ascroft R. C., Krebs W. Selective serotonin reuptake inhibitor discontinuation syndrome: a randomized clinical trial. Biol Psychiatry 1998; 44: 77-87.
55. Lader M. Benzodiazepine dependence. Prog Neuropsychopharmacol Biol Psychiatry 1984; 8: 85-95.